About this trial
The purpose of this study is to identify the risk factors of bone metastasis in breast cancer patients so as to develop a dynamic prediction model using real world clinical data. The multicenter data will be retrospectively collected, and the clinical characteristics related to bone metastasis will be analyzed.
Eligibility criteria
Qualifiers
Patients diagnosed with breast cancer by histopathology;
Age between 20 and 70 years old;
The first diagnosis time is between 2010 and 2020;
Complete diagnosis and treatment information, including basic information, breast cancer diagnosis, surgery, recurrence diagnosis data (including the diagnosis of the metastasis sites), anti-tumor treatment data, bone health and bone metastasis-related diagnosis and treatment data, etc.;
Disqualifiers
Missing important basic information (including initial and recurrent pathology, stage, pathological grade and time, surgery time, and drug treatment);
With distant metastasis at the initial diagnosis;
Patients with autoimmune diseases or aggressive viral infections (such as HIV or hepatitis);
Other malignant tumors;
Trial design
Treatments tested in this trial
- Breast cancer patients with bone metastasis
- Breast cancer patients without bone metastasis